SPRINGWORKS THERAPEUTICS, INC. Marketable Securities
SPRINGWORKS THERAPEUTICS, INC. had Marketable Securities of $224.10 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2025-05-09
- 2025-03-31: Marketable Securities $224.10M.
- 2024-12-31: Marketable Securities $238.23M.
- 2024-09-30: Marketable Securities $292.16M.
- 2024-06-30: Marketable Securities $303.99M.
| Period end | Marketable Securities |
|---|---|
| 2025-03-31 | $224.10M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $238.23M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $292.16M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $303.99M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $318.55M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $303.15M 10-K · filed 2025-02-20 |
| 2023-09-30 | $323.52M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $361.71M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $425.74M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $524.72M 10-K · filed 2024-02-27 |
| 2022-09-30 | $175.51M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $264.97M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $266.34M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $269.54M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $334.06M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $378.21M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $381.99M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $361.39M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $191.99M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $64.57M 10-Q · filed 2020-08-12 |